James Wan and Jason Blum have officially revealed the new umbrella name for their combined horror production companies. The merged entity, formed by bringing together Blumhouse and Atomic Monster, will now operate under the title Blumhouse Atomic. Despite the unification, the two original brands will continue to function as distinct production labels. Creative teams associated with each banner will continue to develop and produce film and television projects under their respective names.
Jason Blum, co-founder of the new entity, described the move as a natural progression of their collaborative history. He noted that the union has proven that the whole is greater than the sum of its parts. Blum highlighted the extensive portfolio of horror franchises now under one roof, including The Conjuring, Insidious, and Saw. He emphasized that bringing the Saw franchise back to Wan, with a new chapter currently in development, exemplifies the synergy of the partnership. The leadership team stated that they now possess the output capacity of a major studio while maintaining the creative freedom and financial discipline typical of an independent company.
The merger, which took place in 2024, combined two of the most successful production houses in the horror genre. Since the union, the combined banners have achieved significant commercial success. They have generated more than 2.5 billion dollars in worldwide box office revenue, all against combined production budgets of less than 330 million dollars. This financial efficiency has been a hallmark of their business model.
The year 2026 has been particularly strong for the newly branded company. Blumhouse Atomic has pulled in 1.3 billion dollars so far this year, driven by two major hits. These include Obsession, directed by Curry Barker, which earned 520 million dollars worldwide, and Backrooms, directed by Kane Parsons, which grossed 400 million dollars globally. These successes have further solidified the company's position in the market.
James Wan, the other co-founder, stressed the importance of discovering new voices in the horror landscape. He expressed a personal commitment to supporting filmmakers who, like him, started with small projects and were given the chance to prove themselves. Wan cited his work with directors such as Kane Parsons, Curry Barker, Josh Giuliano, and Dylan Clark as key examples of this approach. The goal is to provide these filmmakers with the freedom to create distinctive work and to build lasting professional relationships that extend beyond single films.
To further support its mission of creating blockbuster horror from smaller budgets, the company has made several strategic hires and deals. Sam Zimmerman was recently appointed as senior vice president of development and acquisitions. His role involves developing a slate of genre features, with a specific focus on projects that have budgets under 5 million dollars. Additionally, the company recently signed a first-look deal with Divide/Conquer to develop high-concept projects at an economical rate.
Looking ahead, Blumhouse Atomic has announced a substantial film slate for 2027. The upcoming lineup includes a variety of titles that span established franchises and new concepts. The list features River, The Revenge of La Llorona, The Exorcist: Martyrs, and Anything But Ghosts. It also includes entries from popular series such as Paranormal Activity, Blair Witch, and Molepeople, alongside new projects like Sleepover and Seasons.
This strategic expansion reflects the company's intent to take these stories beyond traditional theatrical releases. As Blum mentioned, there are now more opportunities than ever to adapt these properties into television, video games, and live experiences. The rebranding to Blumhouse Atomic marks a significant milestone in the careers of both Wan and Blum, as they continue to define the modern horror landscape.
